sulforaphane has been researched along with gemcitabine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Ahmed, M; Hassan, AH; Hussain, A; Priyani, A; Sadrieh, L; Sharma, C | 1 |
Ahmed, M; Brahmbhatt, K; Hussain, A; Priyani, A; Sadrieh, L; Sharma, C | 1 |
Begum, S; Harish, G; Hussain, A; Javed, E; Khan, MA; Mohsin, J; Nusri, Qel-A; Prabhu, SA; Sharma, C | 1 |
Forster, T; Gebhard, MM; Gerhauser, C; Giese, N; Gladkich, J; Gross, W; Heilmann, K; Herr, I; Isayev, O; Labsch, S; Liu, L; Mattern, J; Nessling, M; Nwaeburu, CC; Rausch, V; Richter, K; Schaefer, M; Schemmer, P; Schoensiegel, F; Werner, J; Zhang, Y | 1 |
Bauer, N; Fan, P; Gao, C; Gladkich, J; Gross, W; Herr, I; Liu, L; Mattern, J; Schemmer, P; Xiao, X; Yin, Y; Zhang, Y; Zhao, Z | 1 |
Georgikou, C; Gladkich, J; Gretz, N; Gross, W; Herr, I; Karakhanova, S; Schäfer, M; Sticht, C; Torre, C; Xiao, X; Yin, L | 1 |
Akahane, T; Iwai, S; Kaji, K; Kitagawa, K; Kubo, T; Mitoro, A; Namisaki, T; Nishimura, N; Shibamoto, A; Suzuki, J; Tomooka, F; Yoshiji, H | 1 |
7 other study(ies) available for sulforaphane and gemcitabine
Article | Year |
---|---|
Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells.
Topics: Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Cyclooxygenase 2; Deoxycytidine; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Inflammation; Interleukin-1beta; Isothiocyanates; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Sulfoxides; Thiocyanates; Uterine Cervical Neoplasms | 2011 |
Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells.
Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Deoxycytidine; Down-Regulation; Drug Synergism; Eugenol; Female; Gemcitabine; HeLa Cells; Humans; Interleukin-1beta; Isothiocyanates; Proto-Oncogene Proteins c-bcl-2; Sulfoxides; Thiocyanates; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2012 |
Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Deoxycytidine; Down-Regulation; Drug Synergism; Female; Gemcitabine; Humans; Isothiocyanates; MCF-7 Cells; Proto-Oncogene Proteins c-bcl-2; Sulfoxides | 2013 |
Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Carcinoma, Pancreatic Ductal; Case-Control Studies; Cell Communication; Cell Proliferation; Connexin 43; Deoxycytidine; Drug Resistance, Neoplasm; Gap Junctions; Gemcitabine; Humans; Immunoenzyme Techniques; Isothiocyanates; Microscopy, Electron; Pancreas; Pancreatic Neoplasms; Phosphorylation; RNA, Small Interfering; Spheroids, Cellular; Sulfoxides; Tumor Cells, Cultured | 2014 |
Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Cell Survival; Clone Cells; Deoxycytidine; Diet; Disease Progression; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Neoplastic Stem Cells; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Phytochemicals; Quercetin; Sulfoxides | 2016 |
Inhibition of miR30a-3p by sulforaphane enhances gap junction intercellular communication in pancreatic cancer.
Topics: Adult; Aged; Animals; Cell Communication; Cell Line, Tumor; Connexin 43; Deoxycytidine; Female; Gap Junctions; Gemcitabine; Gene Expression Regulation, Neoplastic; Heterografts; Humans; In Situ Hybridization; Isothiocyanates; Male; Mice; MicroRNAs; Middle Aged; Pancreatic Neoplasms; Signal Transduction; Sulfoxides | 2020 |
Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity.
Topics: Animals; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; G2 Phase Cell Cycle Checkpoints; Gemcitabine; Humans; Mice | 2023 |